Search Results 71-80 of 17252 for metabolic peptides
Dr. Lanza leads a research team at Mayo Clinic that is advancing exercise physiology research in the context of aging and metabolic disease.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... This medicine is also used to treat metabolic ... For metabolic dysfunction-associated ...
The bone and mineral metabolism research group in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research at Mayo Clinic studies ...
... metabolic syndrome —a set of conditions that increase risk for cardiovascular diseases and diabetes. They report that stem cells in pigs with metabolic ...
About this study. The aim of this investigation is to determine if patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and ...
But patients with ovarian cancer derive limited benefit from current approaches. A major barrier is the unique metabolic and immunosuppressive tumor ...
The purpose of this study is to determine if diverticulosis is associated with metabolic syndrome factors such as hypertension and obesity independently from ...
... metabolic disorders. Getting the right diagnosis leads to the best treatment decisions. Publications. See a list of publications about inherited metabolic ...
Dr. Nair's team in the Metabolic Basis for Type 2 Diabetes and Aging Research Lab at Mayo Clinic focuses on the role of energy metabolism and altered ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!